Kidney Cancer

Childhood cancer survivors need long-term surveillance to keep up with late-term effects, screenings, and other health-related issues.

Researchers identify what survivors need to get physically active.

Childhood cancer survivors find lifelong care at ACE program.

New drug therapies aid in the treatment of prostate cancer, glioblastoma, and renal cell carcinoma.

CURE chooses the winning essay for it 2009 Extraordinary Healer Award for Oncology Nursing.

Reorienting kids to their academic and social lives after cancer.

Are we closer to treating advanced kidney cancer as a chronic disease?

New therapies are making headway in a difficult-to-treat cancer.

The risk of secondary cancers in childhood cancer survivors and what survivors can do to protect themselves.

Childhood cancer survivors skip needed mammograms

Childhood cancer patients make their mark in art exhibit

What I didn't know then about childhood cancer.

New law funds pediatric cancer research.

Updates from the 2008 annual meeting of the American Society of Clinical Oncology includes news on lung, breast, colorectal, and kidney cancers.

Childhood cancer garners sympathy from all, but drug development from few.

Adult cancers are biologically different from childhood cancer, resulting in different treatments and different success rates.

Researchers explore ways to improve drug evaluations in pediatric clinical trials.

Advocates are working together to increase awareness and research in childhood cancers.

Drug development in childhood cancer has picked up the pace in recent years.

Childhood cancer survivors are at higher risk for heart disease.

Igniting progress in the cure of children with cancer.

Twins' blood may explain how childhood leukemia develops.

Lu Sipos' Chemo Duck comforts childhood cancer patients.

Blood counts predict leukemia survival and relapse.

Senate passes the Conquer Childhood Cancer Act for research funding.

Some cancer therapies can increase the risk of secondary cancers such as sarcoma, especially for childhood cancer survivors.

Delayed diagnosis too common.

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.

Genetic nondiscrimination bill on its way to becoming law.